These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8084305)

  • 1. Implantable cardioverter/defibrillators (ICDs).
    Med Lett Drugs Ther; 1994 Sep; 36(932):86-8. PubMed ID: 8084305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 3. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient.
    Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D
    Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
    Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
    John RM; Stevenson WG
    Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators.
    Kutalek SP; Dreifus LS
    Adv Intern Med; 1993; 38():421-38. PubMed ID: 8438649
    [No Abstract]   [Full Text] [Related]  

  • 9. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
    O'Brien BJ; Yee R
    Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
    [No Abstract]   [Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 11. Stabilizing and resuscitating patients with automatic implantable cardioverter-defibrillators.
    Ellis JI
    West J Med; 1993 Nov; 159(5):595-6. PubMed ID: 8279158
    [No Abstract]   [Full Text] [Related]  

  • 12. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Automatic implanted cardioverter-defibrillators (AICD)].
    Giec L; Trusz-Gluza M
    Kardiol Pol; 1992 Dec; 37(12):405-9. PubMed ID: 1293351
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal outcome from inappropriate defibrillation.
    Dimitri H; John B; Young GD; Sanders P
    Europace; 2007 Nov; 9(11):1059-60. PubMed ID: 17827163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.